No Data
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Alnylam Pharmaceuticals on Track for Record High Close -- Data Talk
Alnylam Pharmaceuticals, Inc (ALNY) is currently at $245.68, up $5.53 or 2.3% --Would be new all-time high (Based on available data back to May 28, 2004) --Would be the first record close since Dec.
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $234 to $291
On Jun 26, major Wall Street analysts update their ratings for $Alnylam Pharmaceuticals(ALNY.US)$, with price targets ranging from $234 to $291.Morgan Stanley analyst Michael Ulz maintains with a hold
Form 144 | Alnylam Pharmaceuticals(ALNY.US) Director Proposes to Sell 2.04 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 25, $Alnylam Pharmaceuticals(ALNY.US)$ Director SCHULMAN AMY W intends to sell 8,500 shares of its common stock on Jun 25, with a total market value of approximately $2.04
Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study
(Updates to reflect stock price movement in the headline and first paragraph.) Alnylam Pharmaceuticals (ALNY) shares were up more than 6% in recent Tuesday trading, a day after the company said vutris
Alnylam Pharmaceuticals Price Target Raised to $295.00/Share From $248.00 by B of A Securities
Alnylam Pharmaceuticals Price Target Raised to $295.00/Share From $248.00 by B of A Securities